Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 2
1982 2
1991 2
1992 1
1993 1
1994 2
1996 2
1997 1
2000 5
2001 8
2002 4
2003 3
2004 1
2005 1
2006 3
2007 3
2008 1
2009 3
2010 1
2011 3
2012 8
2013 5
2014 5
2015 2
2016 3
2017 6
2018 15
2019 21
2020 20
2021 34
2022 35
2023 24
2024 21
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.
Boevé LMS, Hulshof MCCM, Vis AN, Zwinderman AH, Twisk JWR, Witjes WPJ, Delaere KPJ, Moorselaar RJAV, Verhagen PCMS, van Andel G. Boevé LMS, et al. Among authors: vis an. Eur Urol. 2019 Mar;75(3):410-418. doi: 10.1016/j.eururo.2018.09.008. Epub 2018 Sep 25. Eur Urol. 2019. PMID: 30266309 Clinical Trial.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
A soft robotic total artificial hybrid heart.
Arfaee M, Vis A, Bartels PAA, van Laake LC, Lorenzon L, Ibrahim DM, Zrinscak D, Smits AIPM, Henseler A, Cianchetti M, Dankers PYW, Bouten CVC, Overvelde JTB, Kluin J. Arfaee M, et al. Among authors: vis a. Nat Commun. 2025 Jun 3;16(1):5146. doi: 10.1038/s41467-025-60372-6. Nat Commun. 2025. PMID: 40461487 Free PMC article.
Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager.
King LA, Veth M, Iglesias-Guimarais V, Blijdorp I, Kloosterman J, Vis AN, Roovers RC, Hulsik DL, Riedl T, Adang AEP, Parren PWHI, van Helden PM, de Gruijl TD, van der Vliet HJ. King LA, et al. Among authors: vis an. iScience. 2024 Oct 30;27(12):111289. doi: 10.1016/j.isci.2024.111289. eCollection 2024 Dec 20. iScience. 2024. PMID: 39628574 Free PMC article.
Reply by Authors.
Meijer D, de Barros HA, van Leeuwen PJ, Bodar YJL, van der Poel HG, Donswijk ML, Hendrikse NH, van Moorselaar RJA, Nieuwenhuijzen JA, Oprea-Lager DE, Vis AN. Meijer D, et al. Among authors: vis an. J Urol. 2021 Jun;205(6):1662. doi: 10.1097/JU.0000000000001592.02. Epub 2021 Mar 18. J Urol. 2021. PMID: 33734856 No abstract available.
Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410-8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?
Boevé LMS, Vis AN. Boevé LMS, et al. Among authors: vis an. Eur Urol. 2019 Apr;75(4):e101-e102. doi: 10.1016/j.eururo.2018.11.034. Epub 2018 Nov 30. Eur Urol. 2019. PMID: 30503181 No abstract available.
Reply by Authors.
Meijer D, Luiting HB, van Leeuwen PJ, Remmers S, Jansen BHE, Bodar YJL, Witteveen T, Schaake EE, van der Poel HG, Wondergem M, Busstra MB, Nieuwenhuijzen JA, Meijnen P, Brabander T, van Moorselaar RJA, Hendrikse NH, Oprea-Lager DE, Roobol MJ, Vis AN. Meijer D, et al. Among authors: vis an. J Urol. 2021 Apr;205(4):1108-1109. doi: 10.1097/JU.0000000000001437.02. Epub 2021 Jan 25. J Urol. 2021. PMID: 33493004 No abstract available.
Editorial Comment.
van den Bergh RCN, Vis AN. van den Bergh RCN, et al. Among authors: vis an. J Urol. 2021 Mar;205(3):778-779. doi: 10.1097/JU.0000000000001362.02. Epub 2020 Dec 23. J Urol. 2021. PMID: 33355502 No abstract available.
219 results